Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Immunotherapy |
Vol/bind | 33 |
Udgave nummer | 8 |
Sider (fra-til) | 919-920 |
Antal sider | 2 |
ISSN | 1524-9557 |
Status | Udgivet - 2010 |
ID: 34096289